This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Ashmore | SocGen cuts TP to 365p from 430p, Buy |
| Astrazeneca | Leerink ups TP to $75 from $68, outperform |
| Balfour Beatty | Berenberg ups TP to 350p from 340p, Buy |
| Carillion | Berenberg ups TP to 380p from 360p, Buy |
| Direct Line | Credit Suisse ups TP to 277p from 255p, neutral |
| Eurasia Drilling | UBS ups to Buy from neutral; cuts TP to $33 from $40 |
| Gemfields | JP Morgan ups to neutral from underweight; TP to 36p from 28p |
| Go-Ahead Group | Jefferies ups TP to 2425p from 1825p, Buy |
| Henderson Group | Barclays ups TP to 215p from 205p, underweight |
| Henderson Group | Citigroup ups TP to 237p from 226p, neutral |
| Howden Joinery | UBS ups TP to 420p from 360p, Buy |
| ITV | Berenberg ups TP to 175p from 155p, sell |
| Ladbrokes | Citigroup cuts TP to 110p from 125p, sell |
| Safestore Holdings | Citigroup ups TP to 260p from 215p, Buy |
| SEGRO | Jefferies ups TP to 340p from 317p, Hold |
| Travis Perkins | Citigroup downgrades to neutral from Buy; ups TP to 2040p from 1910p |
| Tullow Oil | SocGen cuts TP to 875p from 960p, Hold |
| Weir Group | Morgan Stanley ups TP to 2250p from 2040p, Equalweight |
| Weir Group | Barclays ups TP to 2700p from 2475p, overweight |
| WPP | Numis cuts TP of 1482p from 1572p, add |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research